ARC
AERI

Absolute Return Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Absolute Return Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-49,595
Closed -$1.05M – 1424
2014
Q1 		$1.05M Buy
+49,595
New +$1M 0.02% 621

Other funds holding AERI

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Absolute Return Capital's AERI Position: Q2 2014 in Review

Absolute Return Capital sold out of Aerie Pharmaceuticals (AERI) in Q2 2014, closing a stake of 49,595 shares — an estimated $1.05M sold.

Absolute Return Capital first reported a position in AERI in Q1 2014 and held it in 1 quarter. The position peaked at $1.05M in Q1 2014. 60 funds tracked by Wall St. Rank hold AERI as of Q2 2014.

  • Absolute Return Capital reported no remaining Aerie Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Absolute Return Capital sold 49,595 Aerie Pharmaceuticals shares in Q2 2014, an estimated $1.05M.
  • Absolute Return Capital first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Absolute Return Capital's Aerie Pharmaceuticals position peaked at $1.05M in Q1 2014.
  • 60 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2014.

Based on Absolute Return Capital's 13F filing for Q2 2014, filed 14 Aug 2014.